September 20, 2018
Time Frame : Daily/Weekly
Sector : Pharmaceuticals/Healthcare
Key Stats : $789.12 Million Market Cap, VWAP 1.635, ASX Ranking 271, 4 Week Av Turnover $1,418,834, Todays Current Turnover (intraday) $292,890.
Company Overview : Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells. Its intellectual property covers applications in key markets including the United States, Europe, Japan and China.
Broker Consensus : Buy
MSB is being held up by buyers as price holds higher levels. The recent annual report was positive which we expect to attract further buyers to the action. Watching now for a push up through 1.75 for the buy entry with the stop loss to be held at 1.55. If price falls below 1.55 prior to entry, we will cancel the alert and re-assess the price action.
Stock Code : MSB – Mesoblast Limited
Company Website : www.mesoblast.com
Current Price : 1.645
Status : On watch for a Buy entry trigger
You may also like these. If not, just go back to the overview:Overview